
Therapeutic Area | MeSH |
|---|---|
| urogenital diseases | D000091642 |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| SEROPHENE | EMD Serono | N-018361 DISCN | 1982-03-22 | 1 products |
| CLOMID | Sanofi | N-016131 DISCN | 1982-01-01 | 1 products, RLD |
Brand Name | Status | Last Update |
|---|---|---|
| clomid | ANDA | 2025-01-31 |
| clomiphene citrate | ANDA | 2025-09-18 |
| milophene | ANDA | 2024-12-01 |
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| male infertility | EFO_0004248 | D007248 | N46 |
| female infertility | EFO_0008560 | D007247 | N97 |
Code | Description |
|---|---|
| G9940 | Documentation of medical reason(s) for not on a statin (e.g., pregnancy, in vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease during the measurement period or prior year) |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anovulation | D000858 | — | — | — | 1 | — | — | — | 1 |
| Drug common name | Clomiphene |
| INN | clomifene |
| Description | Clomifene, also known as clomiphene, is a medication used to treat infertility in women who do not ovulate, including those with polycystic ovary syndrome. Use results in a greater chance of twins. It is taken by mouth once a day, with a course of treatment that usually lasts for five days.
|
| Classification | Small molecule |
| Drug class | Selective estrogen receptor modulator; Progonadotropin |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1 |
| PDB | — |
| CAS-ID | 911-45-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2355051 |
| ChEBI ID | 3752 |
| PubChem CID | 2800 |
| DrugBank | DB00882 |
| UNII ID | 1HRS458QU2 (ChemIDplus, GSRS) |






